tirzepatide heart In the SUMMIT trial, researchers examined cardiovascular outcomes of treatment with in patients with failure with preserved ejection fraction and obesity. Full trial results and Plain Language Summary: https://nej.md/4hRGaTY Medthreads Tirzepatide and Cardiovascular Outcomes: A

The phenomenon of ligand-directed signalling bias for GLP-1R has recently been described using the endpoints of cAMP production, pERK1/2 and intracellular Ca 2+

Regarding weight management , NICE Technology Appraisals provide specific guidance: TA875 recommends semaglutide 2.4 mg (Wegovy) as an option for managing overweight and obesity alongside a reduced-calorie diet and increased physical activity

While GLP-1 receptors are expressed primarily in pancreatic beta cells, the gastrointestinal tract, and certain areas of the central nervous system, the expression and function of these receptors in joint tissues is not well characterized

Although genetic factors are certainly at play, nature (genes) vs nurture (environment) still holds true, and our food system has changed

A fuller lower lip with a smaller upper lip can look balanced on one face and less balanced on another